H.C. Wainwright initiated coverage on Sagimet Biosciences with a new price target
$SGMT
Biotechnology: Pharmaceutical Preparations
Health Care
H.C. Wainwright initiated coverage of Sagimet Biosciences with a rating of Buy and set a new price target of $32.00